ForSight VISION5
Menlo Park
About ForSight VISION5
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $59.6M
- Funding stage: M&A
- Last round: Debt Financing (Apr 2016)
- Website: forsightvision5.com
- Phone: [email protected]
Industries & Categories
Health Care, Incubators, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/forsight-vision5-182511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.